As macro liquidity expectations shift once again in the second half of 2026, capital is quietly spilling over from crowded mega-cap tech names. I'm told that institutional investors are not only reassessing valuation gaps but actively hunting for special situations with idiosyncratic catalysts. This diverse cohort—ranging from legacy coal miners and niche manufacturers to biotech upstarts—perfectly encapsulates this under-the-radar rotation, with many seeing the most significant overhauls in their respective pipelines.

Alliance Resource Partners (ARLP.US)

Alliance Resource Partners has outperformed several legacy energy peers so far this year. I've learned that in early July 2026, the second-largest eastern U.S. coal producer closed a massive USD 206M acquisition of oil and gas mineral interests. Funded through cash on hand and a new USD 150M term loan, this move is poised to significantly broaden its energy platform before the next earnings cycle.

Faeth Therapeutics (FTH.US)

This biotech firm, focused on PI3K/AKT/mTOR pathway inhibitors, is making waves following its June 2026 rebranding from Sensei Biotherapeutics. According to people familiar with the matter, the dosing of its first breast cancer patient in a Phase 1b/2 trial for PIKTOR in May was a critical milestone. The steady clinical progress helped the stock secure a market outperform rating in July as investor attention builds.

Tungray Technologies (TRSG.US)

Shares of Tungray Technologies have been trading in a higher range recently. The Singapore-based ETO manufacturing provider for the semiconductor and appliance sectors just posted strong financials. First-half 2025 total revenue jumped 37.0% to USD 7.4M, yielding a net income of USD 500,000 and successfully turning a profit. I'm told the summer appointment of a new CFO is designed to tighten global financial controls moving forward.

Innovation Beverage Group (IBG.US)

Despite making a splash in July 2026 with its U.S. and U.K. market expansion, this premium beverage maker's stock remains under pressure due to compliance headwinds. The company managed to close a USD 6M public offering in March, but received a Nasdaq warning in May for a delayed annual filing. Management now faces a tight 60-day window to submit a compliance plan.

Methode Electronics (MEI.US)

The custom-engineered mechatronics supplier has seen its stock recover moderately from its 52-week lows. However, a true turnaround is still pending, as profit margins remain squeezed—with recent gross margins hovering around 19.9%. People close to the company indicate that leadership is urgently targeting high-margin contracts in the cloud computing and automotive supply chains.

Also

• Turbo Energy (TURB.US): The Spanish solar storage firm regained Nasdaq compliance in June 2026 and recently deployed AI-driven infrastructure across 15 European industrial facilities.
• Singapore Telecommunications (SGAPY.US): The telco giant, boasting over 4.5M mobile users in its home market, signed a key partnership with Ericsson in March 2026 to accelerate its 5G Advanced rollout.
• Artisan Partners Asset Management (APAM.US): The global investment firm continues to deploy multiple high-value asset strategies while fiercely protecting its autonomous investment team model.
• Femto Technologies (FMTOF.US): The Israel-based CRM software developer, currently trading OTC, holds over USD 16.1M in short-term assets, more than enough to cover its near-term liabilities.
• QQQW (QQQW.US): This actively managed ETF continues to offer investors 2x leveraged exposure to the Nasdaq-100's weekly returns through swap agreements, with an expense ratio of around 1.3%.

This article does not constitute investment advice.